We found that ATM inhibition promotes nuclear relocalization of P65 and P52 in CRC cells, demonstrating that ATM inhibition promotes both canonical and noncanonical NF-κB pathway activation in CRC cells. Here, NFKB1 is linked to colorectal carcinoma.